Navigation Links
Celator(R) Pharmaceuticals Announces Appointment of Scott Jackson as CEO
Date:5/9/2008

PRINCETON, N.J., May 9 /PRNewswire/ -- Celator Pharmaceuticals today announced that Scott Jackson has been appointed Chief Executive Officer. Mr. Jackson joined Celator in October 2007 as Head of Commercial Development.

"We are delighted to have Scott as the new CEO. He brings more than 20 years of pharmaceutical experience, including 10 years of specialty pharmaceutical experience primarily in oncology," said Dr. Joseph Mollica, Chairman of Celator's Board of Directors. "His senior management experience and commercial and clinical development knowledge will be extremely valuable to the organization as the company moves forward."

Mr. Jackson has extensive experience in the pharmaceutical and biotechnology industry and has held positions of increasing responsibility in sales, marketing, and commercial development at Eli Lilly & Co., SmithKline Beecham, ImClone Systems Inc., Centocor (Johnson & Johnson), Eximias Pharmaceuticals and YM BioSciences. Mr. Jackson holds a B.S. in Pharmacy from the Philadelphia College of Pharmacy and Science and an M.B.A. from the University of Notre Dame. Mr. Jackson succeeds Dr. Andrew Janoff.

"I'm very excited about the future for Celator Pharmaceuticals," said Mr. Jackson. "We have an entrepreneurial spirit and commitment at the company and I look forward to contributing to the company's growth and success."

"Celator has two promising products in clinical development based on the company's proprietary drug ratio technology platform, CombiPlex (TM). Results from a Phase 2 study of CPX-1 (a liposomal formulation of irinotecan:floxuridine) in patients with advanced colorectal cancer will be reported later this year at major medical conferences. Results from a Phase 1 study with CPX-351 (a liposomal formulation of cytarabine:daunorubicin) in patients with advanced leukemias will be submitted to a conference before the end of the year," said Mr. Jackson. "In addition, Celator's CombiPlex (TM) technology pl
'/>"/>

SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
2. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...Newswire/ -- The Ohio Capital Fund today underscor...ity business early-stage capital summits. The eve..."Transforming the Landscape of Business in America... It will feature several speakers including invest...minority entrepreneurs. ,, "The Ohio Capital F...
(Date:11/30/2009)...re-USNewswire/ -- The Michael J. Fox Foundation fo... million in total awards to six research teams wor...apies for Parkinson,s disease. The funding was awa... for Parkinson,s Disease program, made possible b...), a neuroscience-based biotechnology company. ,...
(Date:11/30/2009)... -- Dr. Jessica Torrente, Assistant Professor of R...enter in Washington, D.C., demonstrated the integr...GI) in clinical practice as an adjunct imaging mod...the annual meeting of the Radiological Society of ...hibit was to demonstrate how BSGI is used in the c...
(Date:11/30/2009)...in providing smart and efficient software to the p...eg;, evolutionizing work-from-home histopathology ...software used by 8 of the Top 10 Pharmaceutical Co...de’ basis. , Mount ... announced another evolution in the histopathology...
Breaking Biology Technology:Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
... Dendreon Corporation (Nasdaq:,DNDN) today reporte....,Revenue for the third quarter of 2008 was $26,00...mber 30, 2007. Revenue for the nine months ended,S... for the nine months,ended September 30, 2007., D...uarter of 2008 were,$17.3 million compared to $19....
...isiana, November 7 , - Residual Vascular Risk Red... of the Launch of the Residual Risk Reduction Init... Initiative (R3i) calls for action to reduce the,l... current standards of,care in millions of patients...bon Room, Ritz Carlton Hotel, 921 Canal Street, Ne...
...at could lead to brighter LCD screens, more effici...high-tech security sensors has won the University ...n PhD. , Dr Daniel Gomez, who completed his thesi...n the properties of semiconductor nano-crystals, p...s now expanding on his work as a Research Fellow a...
Other Biology Technology:Dendreon Reports Third Quarter 2008 Financial Results 2Dendreon Reports Third Quarter 2008 Financial Results 3Dendreon Reports Third Quarter 2008 Financial Results 4Dendreon Reports Third Quarter 2008 Financial Results 5Winning University of Melbourne Ph.D. research boosts the search for sensitive sensors 2
(Date:11/30/2009)...rst comprehensive review of the state of Antarctic...mate system is published this week (Tuesday 1 Dece...earch (SCAR). The review - Antarctic Climate Chan...ch from the icy continent, identifies areas for fu... questions that policy makers have about Antarctic...
(Date:11/30/2009)...release is available in German . , The DFG ...tive Research Centres as of 1 January 2010. This d...ommittee in Bonn. The new centres will initially b...n. In addition, 20 percent overhead funding for in...t. The centres, research topics range from modern ...
(Date:11/30/2009)...-called invasion proteins are crucial for infectio...f human cells, which stimulates the host cell to t...cules exert a different function, for example the ...roup,s results have now been published in the curr... , Spoiled meat is one of the sources for Liste...
Breaking Biology News(10 mins):First comprehensive review of the state of Antarctica's climate 2DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9It takes 2 to infect 2Virginia Restaurants Urged to Go Completely Smoke Free After Major Report Finds Smoke Free Laws Prevent Heart Attacks 59687 1Virginia Restaurants Urged to Go Completely Smoke Free After Major Report Finds Smoke Free Laws Prevent Heart Attacks 59687 2Virginia Restaurants Urged to Go Completely Smoke Free After Major Report Finds Smoke Free Laws Prevent Heart Attacks 59687 3Court Imposes Record Fine and Forfeiture of 241 3 Billion for Pharmacia 26amp 3B Upjohn Companys Fraudulent Marketing of Bextra 59685 1Court Imposes Record Fine and Forfeiture of 241 3 Billion for Pharmacia 26amp 3B Upjohn Companys Fraudulent Marketing of Bextra 59685 2Court Imposes Record Fine and Forfeiture of 241 3 Billion for Pharmacia 26amp 3B Upjohn Companys Fraudulent Marketing of Bextra 59685 3Court Imposes Record Fine and Forfeiture of 241 3 Billion for Pharmacia 26amp 3B Upjohn Companys Fraudulent Marketing of Bextra 59685 4Possible Novel H1N1 Cases in Pigs Not Unexpected 3B Experts Say U S Pork Is Safe to Eat 59683 1
...tems, following the most devastating extinction ev...ccording to new research from the University of Br...of the Permian, a major extinction event killed ov..., plants, marine animals, amphibians, and reptiles... were restructured and organisms were left struggl...
...of coastal ecosystem services such as clean water,...ve to be an all-or-nothing approach, a new study i...tems actually respond to protection efforts in a n...vironmental-versus-economic gridlock. , There may...vironmental protection needed while still maintain...
...ting state and federal fishery agencies, regional ...oups, and fishing and other marine industries, wil...Santa Cruz, Calif., on Feb., 4 8, for the fifteen...Groundfish Conference is the only such conference ...h biologist with NOAA Fisheries Service. It is the...
Other Biology News:Recovering from a mass extinction 2'Nonlinear' ecosystem response points to environmental solutions 2'Nonlinear' ecosystem response points to environmental solutions 3
Immunochemistry 2 from Promega
Feline IL-4 ELISA development Kit, DuoSet Economy Pack from R&D Systems
LabFax: Immunochemistry from Promega
Essential Techniques: Antibody Production from Promega
Biology Products: